AbbVie

No reviews yet · Write a Review
AbbVie is a global, research-driven biopharmaceutical company committed to developing innovative advanced therapies for some of the world’s most complex and critical conditions.

Company Details

Address
1 North Waukegan Road
North Chicago, IL 60064

Competitors of AbbVie

GEA supplies advanced processing technologies for the manufacturing of oral and parenteral dosage forms. We partner with customers to develop new products and enhance clinical effectiveness; the supply of R&D-scale and stand-alone production equipment; and installation of complete integrated... Read More

3 Products 0 White Papers 0 Press Releases

HOVIONE is dedicated to cGMP manufacture of APIs, as a CMO and API supplier. Coupled with our long history of process chemistry is our expertise in particle design. Spray-drying, spray-congealing, freeze-drying, micronization and cryomilling capabilities allow us to offer a wide range of solutions... Read More

0 Products 0 White Papers 0 Press Releases

Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Read More

0 Products 0 White Papers 0 Press Releases

News & Press Releases

View All
Press Release

AbbVie and Iambic Announce Collaboration to Accelerate AI-driven Drug Discovery

Published: 9/21/2026 →
Press Release

AbbVie Extends Migraine Leadership with Positive Phase 3 Atogepant Results in Menstrual Migraine

Published: 9/10/2026 →
Press Release

AbbVie Completes Acquisition of Apogee Therapeutics

Published: 9/3/2026 →
Press Release

SkinMedica® Adds Barrier Calming Cream to its Collection of Regenerative Skincare Offerings

Published: 9/1/2026 →
Press Release

AbbVie to Present New Data at WCLC 2026 Showcasing Innovation Across Lung Cancer Pipeline

Published: 8/21/2026 →
Press Release

AbbVie Announces 2026 AbbVie Immunology Scholarship Recipients, Celebrating 10 Years of Support

Published: 8/18/2026 →
Press Release

JUVÉDERM® Day Returns to U.S. on August 19

Published: 7/30/2026 →
Press Release

SKYRIZI® (risankizumab-rzaa) Now FDA Approved for Pediatric Use in Psoriatic Disease

Published: 6/26/2026 →
Press Release

AbbVie Presents New Data Across Its Blood Cancer Portfolio at EHA 2026

Published: 6/8/2026 →